Provided by Tiger Fintech (Singapore) Pte. Ltd.

Marker Therapeutics, Inc.

1.58
+0.05003.27%
Volume:654.04K
Turnover:986.89K
Market Cap:17.88M
PE:-1.18
High:1.62
Open:1.53
Low:1.43
Close:1.53
Loading ...
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Sep 24, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Aug 19, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Aug 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 15, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 15, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Aug 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 09, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 08, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Aug 08, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 06, 2019

Major Issues Report

Current report, items 5.02, 7.01, and 9.01
Jul 22, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Jul 19, 2019

Major Issues Report

Current report, item 7.01
Jun 21, 2019

Correspondence

[Cover]Correspondence
Jun 20, 2019

Major Issues Report

Current report, items 7.01 and 9.01
May 10, 2019

Major Issues Report

Current report, item 5.07
May 10, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 09, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 13, 2018

Correspondence

[Cover]Correspondence